Eric Dobmeier

Mr. Eric L.
Dobmeier is a Chairman at Jade Biosciences, Inc., an Independent Director at Janux Therapeutics, Inc., a Venture Partner at Samsara BioCapital LLC and an Independent Director at Structure Therapeutics, Inc. He is on the Board of Directors at Jade Biosciences, Inc. (United States), Janux Therapeutics, Inc. and Structure Therapeutics, Inc. Mr. Dobmeier was previously employed as a Chairman, President & Chief Executive Officer by Chinook Therapeutics, Inc., a President, Chief Executive Officer & Director by Chinook Therapeutics U.S., Inc., a President, Chief Executive Officer & Director by Chinook Therapeutics, Inc. /Old/, a President & Chief Executive Officer by Silverback Therapeutics, Inc., an Independent Director by Adaptive Biotechnologies Corp., an Independent Director by Atara Biotherapeutics, Inc., an Independent Director by Stemline Therapeutics, Inc., a Chief Operating Officer by Seattle Genetics, Inc., an Attorney by Heller Ehrman LLP, and an Attorney by Venture Law Group.
He also served on the board at Versartis, Inc. He received his undergraduate degree from Princeton University and a graduate degree from Berkeley Law University of California.